Aptus Pharma
add_icon

Aptus Pharma

161.00
-1.00
(-0.62%)
Market Cap
₹110.41 Cr
PE Ratio
-
Volume
42,000.00
Day High - Low
₹165.00 - ₹155.50
52W High-Low
₹169.00 - ₹80.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
110.41 Cr
EPS
6.37
PB Ratio
5.56
Book Value
29.13
EBITDA
4.90
Dividend Yield
0.00 %
Return on Equity
44.50
Debt to Equity
1.79
Forecast For
Actual

Company News

View All News
Caret
positive
Aptus Pharma Limited announces significant expansion of its OTC business in Gujarat through AptusWellCare Division, focusing on face care, body care, and hair care products with flagship brands.
neutral
Trump reveals Apple CEO shared concerns about recruitment difficulties during recent conversation, highlighting ongoing talent acquisition challenges in tech sector.
positive
Aptus Pharma has launched a new urology therapy segment as part of its business expansion strategy. The company aims to use this new therapeutic area to drive revenue growth and diversify its pharmaceutical portfolio.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,535.50
#1 1,04,225.50
47.69
#1 24,630.60
14.26
#1 2,203
#1 64,800.00
38.15
1,394.70
46,148.49
85.03
15,737.30
23.58
834
-76.28
56.05
1,777.40
36,545.97
66.48
12,042.70
23.73
591
2.81
47.64
6,660.00
23,409.20
102.06
10,046.60
#1 48.08
251
-252.86
40.70
257.40
16,574.00
34.61
7,932.40
7.48
564
-41.14
43.92
330.55
14,411.94
50.31
5,598.70
14.48
314
3.00
39.80
637.75
12,334.32
66.29
2,451.50
11.53
164
31.87
57.49
923.90
11,721.69
#1 33.97
8,110.20
15.97
363
-21.87
30.33
621.30
8,508.70
82.19
2,789.50
1.31
108
20.84
38.02
1,651.50
6,691.68
52.13
5,126.90
14.69
119
61.78
51.95
Growth Rate
Revenue Growth
37.43 %
Net Income Growth
287.50 %
Cash Flow Change
15.21 %
ROE
-1.51 %
ROCE
105.69 %
EBITDA Margin (Avg.)
127.53 %

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
14
18
25
0
Expenses
13
16
20
0
EBITDA
1
2
5
0
Operating Profit %
4 %
9 %
20 %
0 %
Depreciation
0
0
0
0
Interest
0
0
1
0
Profit Before Tax
0
1
4
0
Tax
0
0
1
0
Net Profit
0
1
3
0
EPS in ₹
1.30
5.32
6.37
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
6
10
22
Fixed Assets
1
1
1
Current Assets
6
8
20
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
6
9
21
Total Liabilities
6
10
22
Current Liabilities
3
4
12
Non Current Liabilities
2
4
3
Total Equity
1
2
7
Reserve & Surplus
1
2
2
Share Capital
0
0
5

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
0
4
Investing Activities
-0
-0
-1
Operating Activities
-0
-2
-2
Financing Activities
1
3
7

Share Holding

% Holding
Jun 2025
Sept 2025
Promoter
72.89 %
72.89 %
FIIs
10.03 %
10.03 %
DIIs
2.80 %
2.80 %
Government
0.00 %
0.00 %
Public / Retail
11.55 %
11.55 %
Others
2.74 %
2.74 %
No of Share Holders
9
9

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 129.20 145.50

Technical Indicators

RSI(14)
Neutral
58.38
ATR(14)
Volatile
4.62
STOCH(9,6)
Neutral
37.38
STOCH RSI(14)
Neutral
22.70
MACD(12,26)
Bearish
-1.66
ADX(14)
Strong Trend
27.43
UO(9)
Bearish
47.39
ROC(12)
Downtrend And Accelerating
-0.92
WillR(14)
Neutral
-59.26